<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39329247</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2050-4527</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Immunity, inflammation and disease</Title><ISOAbbreviation>Immun Inflamm Dis</ISOAbbreviation></Journal><ArticleTitle>Outpatient use of antibiotics in uncomplicated diverticulitis decreases hospital admissions.</ArticleTitle><Pagination><StartPage>e70031</StartPage><MedlinePgn>e70031</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70031</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/iid3.70031</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Recently, antibiotics use in uncomplicated acute diverticulitis (AD) has been controversial in Europe. The American Gastroenterological Association (AGA) in their 2015 guidelines recommend their selective use. Our study highlights their role in outpatient management.</AbstractText><AbstractText Label="METHODS">We queried the Diamond Network through TriNetX-Research Network including 92 healthcare organizations. We included large intestine diverticulitis without perforation, abscess or bleeding. Exclusion criteria included any of sepsis criteria, CRP&#x2009;&gt;&#x2009;15&#x2009;mg/L, immunodeficiency or HIV, coronary artery disease, chronic kidney disease, history of Crohn's disease or ulcerative colitis, heart failure, hypertension, diabetes or any of the following in the 3 months before study date; clostridium difficile (C. diff) infection, diverticulitis or antibiotics. Patients with AD were divided into two cohorts; patients on antibiotics, and patients not on antibiotics. Cohorts were compared after propensity-score matching (PSM).</AbstractText><AbstractText Label="RESULTS">214,277 patients met inclusion criteria. 58.9% received antibiotics, and 41% did not. After PSM, both cohorts had 84,320. Rate of hospital admission was lower in the antibiotic group (3.3% vs 4.2%, p&#x2009;&lt;&#x2009;.001). There was a statistical difference between ICU admission (0.1% vs 0.15%, p&#x2009;&lt;&#x2009;.01) and the rate of bowel perforation, peritonitis, abscess formation or bleeding (1.3% vs 1.4%, p&#x2009;=&#x2009;.044). There was no difference in mortality (0.1% vs 0.1%, p&#x2009;=&#x2009;.11), C. diff (0.1% vs 0.1%, p&#x2009;=&#x2009;.9), colectomies (0.2% vs 0.2%, p&#x2009;=&#x2009;.33), or Acute Kidney Injury (AKI) (0.1% vs 0.1%, p&#x2009;=&#x2009;.28).</AbstractText><AbstractText Label="CONCLUSION">Outpatient use of antibiotics in patients with uncomplicated AD is associated with lower rates of hospital admissions and complications without changing mortality rate or surgical intervention.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Immunity, Inflammation and Disease published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ayoub</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0002-6518-3971</Identifier><AffiliationInfo><Affiliation>Charleston Area Medical Center - West Virginia University Charleston Division, Internal Medicine Department, Charleston, West Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faris</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Surgery Department, Marshall University School of Medicine, Huntington, West Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chumbe</LastName><ForeName>Julton Tomanguillo</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Charleston Area Medical Center - West Virginia University Charleston Division, Internal Medicine Department, Charleston, West Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anwar</LastName><ForeName>Nadeem</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, West Virginia University School of Medicine - Charleston Area Medical Center, Charleston, West Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chela</LastName><ForeName>Harleen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, West Virginia University School of Medicine - Charleston Area Medical Center, Charleston, West Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daglilar</LastName><ForeName>Ebubekir</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, West Virginia University School of Medicine - Charleston Area Medical Center, Charleston, West Virginia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2U54GM104942-02</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104942</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immun Inflamm Dis</MedlineTA><NlmUniqueID>101635460</NlmUniqueID><ISSNLinking>2050-4527</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="Y">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004238" MajorTopicYN="N">Diverticulitis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000553" MajorTopicYN="N">Ambulatory Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibiotics</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Diverticulitis</Keyword><Keyword MajorTopicYN="N">Hospital Admissions</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Outpatient</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword></KeywordList><CoiStatement>All authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>16</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39329247</ArticleId><ArticleId IdType="pmc">PMC11427943</ArticleId><ArticleId IdType="doi">10.1002/iid3.70031</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jacobs DO. Diverticulitis. N Engl J Med. 2007;357(20):2057&#x2010;2066. 10.1056/NEJMCP073228</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMCP073228</ArticleId><ArticleId IdType="pubmed">18003962</ArticleId></ArticleIdList></Reference><Reference><Citation>Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143(5):1179&#x2010;1187.e3. 10.1053/J.GASTRO.2012.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/J.GASTRO.2012.08.002</ArticleId><ArticleId IdType="pmc">PMC3480553</ArticleId><ArticleId IdType="pubmed">22885331</ArticleId></ArticleIdList></Reference><Reference><Citation>Peery AF, Crockett SD, Barritt AS, et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015;149(7):1731&#x2010;1741.e3. 10.1053/J.GASTRO.2015.08.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/J.GASTRO.2015.08.045</ArticleId><ArticleId IdType="pmc">PMC4663148</ArticleId><ArticleId IdType="pubmed">26327134</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharucha AE, Parthasarathy G, Ditah I, et al. Temporal trends in the incidence and natural history of diverticulitis: A population&#x2010;based study. Am J Gastroenterol. 2015;110(11):1589&#x2010;1596. 10.1038/AJG.2015.302</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/AJG.2015.302</ArticleId><ArticleId IdType="pmc">PMC4676761</ArticleId><ArticleId IdType="pubmed">26416187</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabok A, P&#xe5;hlman L, Hjern F, Haapaniemi S, Smedh K. Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg. 2012; 99(4):532&#x2010;539. 10.1002/BJS.8688</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/BJS.8688</ArticleId><ArticleId IdType="pubmed">22290281</ArticleId></ArticleIdList></Reference><Reference><Citation>Isacson D, Smedh K, Nikberg M, Chabok A. Long&#x2010;term follow&#x2010;up of the AVOD randomized trial of antibiotic avoidance in uncomplicated diverticulitis. Br J Surg. 2019;106(11):1542&#x2010;1548. 10.1002/BJS.11239</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/BJS.11239</ArticleId><ArticleId IdType="pubmed">31386199</ArticleId></ArticleIdList></Reference><Reference><Citation>Peery AF, Shaukat A, Strate LL. AGA clinical practice update on medical management of colonic diverticulitis: expert review. Gastroenterology. 2021;vol. 160(3):906&#x2010;911.e1. 10.1053/j.gastro.2020.09.059</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.09.059</ArticleId><ArticleId IdType="pmc">PMC7878331</ArticleId><ArticleId IdType="pubmed">33279517</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanas A, Latella G. Acute diverticulitis. Colonic Diverticul Dis.2023;99&#x2010;109. 10.1007/978-3-030-93761-4_9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-93761-4_9</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;hm SK. Risk factors for diverticulosis, diverticulitis, diverticular perforation, and bleeding: A plea for more subtle history taking. Visc Med. 2015;31(2):84&#x2010;94. 10.1159/000381867</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000381867</ArticleId><ArticleId IdType="pmc">PMC4789955</ArticleId><ArticleId IdType="pubmed">26989377</ArticleId></ArticleIdList></Reference><Reference><Citation>Violi A, Cambi&#xe8; G, Miraglia C, et al. Epidemiology and risk factors for diverticular disease. Acta Bio&#x2010;medica: Atenei Parmensis. 2018;89(suppl 9):107&#x2010;112. 10.23750/ABM.V89I9-S.7924</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/ABM.V89I9-S.7924</ArticleId><ArticleId IdType="pmc">PMC6502189</ArticleId><ArticleId IdType="pubmed">30561403</ArticleId></ArticleIdList></Reference><Reference><Citation>Strate LL, Morris AM. Epidemiology, pathophysiology, and treatment of diverticulitis. Gastroenterology. 2019;156(5):1282&#x2010;1298.e1. 10.1053/J.GASTRO.2018.12.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/J.GASTRO.2018.12.033</ArticleId><ArticleId IdType="pmc">PMC6716971</ArticleId><ArticleId IdType="pubmed">30660732</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosemar A, Anger&#xe5;s U, Rosengren A. Body mass index and diverticular disease: a 28&#x2010;year follow&#x2010;up study in men. Dis Colon Rectum. 2008;51(4):450&#x2010;455. 10.1007/S10350-007-9172-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10350-007-9172-5</ArticleId><ArticleId IdType="pubmed">18157570</ArticleId></ArticleIdList></Reference><Reference><Citation>Aune D, Sen A, Leitzmann MF, Tonstad S, Norat T, Vatten LJ. Tobacco smoking and the risk of diverticular disease &#x2010; a systematic review and meta&#x2010;analysis of prospective studies. Colorectal Dis. 2017;19(7):621&#x2010;633. 10.1111/CODI.13748</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/CODI.13748</ArticleId><ArticleId IdType="pubmed">28556447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopylov U, Ben&#x2010;Horin S, Lahat A, Segev S, Avidan B, Carter D. Obesity, metabolic syndrome and the risk of development of colonic diverticulosis. Digestion. 2012;86(3):201&#x2010;205. 10.1159/000339881</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339881</ArticleId><ArticleId IdType="pubmed">22907510</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakuta H, Suzuki T. Prevalence rates of type 2 diabetes and hypertension are elevated among middle&#x2010;aged Japanese men with colonic diverticulum. Environ Health Prev Med. 2007;12(2):97&#x2010;100. 10.1007/BF02898156</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02898156</ArticleId><ArticleId IdType="pmc">PMC2723646</ArticleId><ArticleId IdType="pubmed">21431826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang SS, Cannom RR, Abbas MA, Etzioni D. Diverticulitis in transplant patients and patients on chronic corticosteroid therapy: a systematic review. Dis Colon Rectum. 2010;53(12):1699&#x2010;1707. 10.1007/DCR.0B013E3181F5643C</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/DCR.0B013E3181F5643C</ArticleId><ArticleId IdType="pubmed">21178867</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronley K, Wenzke J, Hussan H, et al. &#x201c;Diverticulitis in HIV&#x2010;infected patients within the United States. HIV Med. 2016;17(3):216&#x2010;221. 10.1111/HIV.12304</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/HIV.12304</ArticleId><ArticleId IdType="pubmed">26283564</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank DN, St. Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular&#x2010;phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci. 2007;104(34):13780&#x2010;13785. 10.1073/PNAS.0706625104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/PNAS.0706625104</ArticleId><ArticleId IdType="pmc">PMC1959459</ArticleId><ArticleId IdType="pubmed">17699621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gevers D, Kugathasan S, Denson L, et al. The treatment&#x2010;naive microbiome in new&#x2010;onset Crohn's disease. Cell Host Microbe. 2014;15(3):382&#x2010;392. 10.1016/J.CHOM.2014.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CHOM.2014.02.005</ArticleId><ArticleId IdType="pmc">PMC4059512</ArticleId><ArticleId IdType="pubmed">24629344</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels L, Budding AE, de Korte N, et al. Fecal microbiome analysis as a diagnostic test for diverticulitis. Eur J Clin Microbiol Infect Dis. 2014;33(11):1927&#x2010;1936. 10.1007/S10096-014-2162-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10096-014-2162-3</ArticleId><ArticleId IdType="pubmed">24894339</ArticleId></ArticleIdList></Reference><Reference><Citation>Tursi A, Elisei W. Role of inflammation in the pathogenesis of diverticular disease. Mediators Inflamm. 2019;2019(1):1&#x2010;7. 10.1155/2019/8328490</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/8328490</ArticleId><ArticleId IdType="pmc">PMC6437747</ArticleId><ArticleId IdType="pubmed">31001067</ArticleId></ArticleIdList></Reference><Reference><Citation>Niikura R, Nagata N, Akiyama J, Shimbo T, Uemura N. Hypertension and concomitant arteriosclerotic diseases are risk factors for colonic diverticular bleeding: a case&#x2010;control study. Int J Colorectal Dis. 2012;27(9):1137&#x2010;1143. 10.1007/S00384-012-1422-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00384-012-1422-X</ArticleId><ArticleId IdType="pmc">PMC3430839</ArticleId><ArticleId IdType="pubmed">22354135</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuruoka N, Iwakiri R, Hara M, et al. NSAIDs are a significant risk factor for colonic diverticular hemorrhage in elder patients: evaluation by a case&#x2010;control study. J Gastroenterol Hepatol. 2011; 26(6):1047&#x2010;1052. 10.1111/J.1440-1746.2010.06610.X</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/J.1440-1746.2010.06610.X</ArticleId><ArticleId IdType="pubmed">21198829</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris CR, Harvey IM, Stebbings WSL, Hart AR. Incidence of perforated diverticulitis and risk factors for death in a UK population. Br J Surg. 2008;95(7):876&#x2010;881. 10.1002/BJS.6226</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/BJS.6226</ArticleId><ArticleId IdType="pubmed">18509877</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjern F, Wolk A, H&#xe5;kansson N. Smoking and the risk of diverticular disease in women. Br J Surg. 2011;98(7):997&#x2010;1002. 10.1002/BJS.7477</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/BJS.7477</ArticleId><ArticleId IdType="pubmed">21462366</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall J, Hardiman K, Lee S, et al. The American society of colon and rectal surgeons clinical practice guidelines for the treatment of Left&#x2010;Sided colonic diverticulitis. Dis Colon Rectum. 2020;63(6):728&#x2010;747. 10.1097/DCR.0000000000001679</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000001679</ArticleId><ArticleId IdType="pubmed">32384404</ArticleId></ArticleIdList></Reference><Reference><Citation>
Jeger V, Popp R, Forudastan F, J. B.&#x2010;S. medical, and undefined
2017
, Is there a role for procalcitonin in differentiating uncomplicated and complicated diverticulitis in order to reduce antibiotic therapy? A prospective diagnostic, 
zora.uzh.chV Jeger, R Popp, F Forudastan, JP Barras, M Zuber, RJ PisoSwiss medical weekly, 2017&#x2022;zora.uzh.ch
, Accessed: Sep. 05, 2024. [Online]. Available: https://www.zora.uzh.ch/id/eprint/144308/1/smw_147_w14555.pdf
</Citation></Reference><Reference><Citation>Stollman N, Smalley W, Hirano I, et al. American Gastroenterological Association Institute Guideline on the Management of Acute Diverticulitis. Gastroenterology. 2015;149(7):1944&#x2010;1949. 10.1053/J.GASTRO.2015.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/J.GASTRO.2015.10.003</ArticleId><ArticleId IdType="pubmed">26453777</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels L, &#xdc;nl&#xfc; &#xc7;, de Korte N, et al. Randomized clinical trial of observational versus antibiotic treatment for a first episode of CT&#x2010;proven uncomplicated acute diverticulitis. Br J Surg. 2017;104(1):52&#x2010;61. 10.1002/BJS.10309</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/BJS.10309</ArticleId><ArticleId IdType="pubmed">27686365</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dijk ST, Daniels L, &#xdc;nl&#xfc; &#xc7;, et al. Long&#x2010;term effects of omitting antibiotics in uncomplicated acute diverticulitis. Am J Gastroenterol. 2018;113(7):1045&#x2010;1052. 10.1038/S41395-018-0030-Y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41395-018-0030-Y</ArticleId><ArticleId IdType="pubmed">29700480</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaung R, Nisbet S, Gosselink MP, et al. Antibiotics do not reduce length of hospital stay for uncomplicated diverticulitis in a pragmatic double&#x2010;Blind randomized trial. Clin Gastroenterol Hepatol. 2021;19(3):503&#x2010;510.e1. 10.1016/j.cgh.2020.03.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.03.049</ArticleId><ArticleId IdType="pubmed">32240832</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x201c;Randomized, prospective comparison of cefoxitin and gentamicin&#x2010;clindamycin in the treatment of acute colonic diverticulitis &#x2010; PubMed.&#x201d; Accessed: Dec. 11, 2023. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/1638578/
</Citation><ArticleIdList><ArticleId IdType="pubmed">1638578</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribas Y, Bombard&#xf3; J, Aguilar F, et al. Prospective randomized clinical trial assessing the efficacy of a short course of intravenously administered amoxicillin plus clavulanic acid followed by oral antibiotic in patients with uncomplicated acute diverticulitis. Int J Colorectal Dis. 2010;25(11):1363&#x2010;1370. 10.1007/S00384-010-0967-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00384-010-0967-9</ArticleId><ArticleId IdType="pubmed">20526718</ArticleId></ArticleIdList></Reference><Reference><Citation>Dichman ML, Rosenstock SJ, Shabanzadeh DM. Antibiotics for uncomplicated diverticulitis. Cochrane Database Syst Rev. 2022;2022(6). 10.1002/14651858.CD009092.PUB3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD009092.PUB3</ArticleId><ArticleId IdType="pmc">PMC9216234</ArticleId><ArticleId IdType="pubmed">35731704</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra&#x2010;abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(2):133&#x2010;164. 10.1086/649554</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/649554</ArticleId><ArticleId IdType="pubmed">20034345</ArticleId></ArticleIdList></Reference><Reference><Citation>Boermeester MA, Humes DJ, Velmahos GC, S&#xf8;reide K. Contemporary review of Risk&#x2010;Stratified management in acute uncomplicated and complicated diverticulitis. World J Surg. 2016;40(10):2537&#x2010;2545. 10.1007/S00268-016-3560-8/TABLES/3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00268-016-3560-8/TABLES/3</ArticleId><ArticleId IdType="pubmed">27206400</ArticleId></ArticleIdList></Reference><Reference><Citation>Van De Wall BJ, Draaisma WA, Consten E, et al. DIRECT trial. diverticulitis recurrences or continuing symptoms: operative versus conservative treatment. A multicenter randomised clinical trial. BMC Surg. 2010;10:25. 10.1186/1471-2482-10-25</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2482-10-25</ArticleId><ArticleId IdType="pmc">PMC2928179</ArticleId><ArticleId IdType="pubmed">20691040</ArticleId></ArticleIdList></Reference><Reference><Citation>Au S, Aly EH. Treatment of uncomplicated acute diverticulitis without antibiotics: A systematic review and meta&#x2010;analysis. Dis Colon Rectum. 2019;62(12):1533&#x2010;1547. 10.1097/DCR.0000000000001330</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000001330</ArticleId><ArticleId IdType="pubmed">30663999</ArticleId></ArticleIdList></Reference><Reference><Citation>Schechter S, Mulvey J, Eisenstat TE. Management of uncomplicated acute diverticulitis: results of a survey. Dis Colon Rectum. 1999;42(4):470&#x2010;475. 10.1007/BF02234169</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02234169</ArticleId><ArticleId IdType="pubmed">10215046</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirany AME, Gaertner WB, Madoff RD, Kwaan MR. Diverticulitis diagnosed in the emergency room: is it safe to discharge home? J Am Coll Surg. 2017;225(1):21&#x2010;25. 10.1016/J.JAMCOLLSURG.2017.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JAMCOLLSURG.2017.02.016</ArticleId><ArticleId IdType="pubmed">28450063</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwood&#x2010;Ericksen M, Havens J, Ma J, Weissman J, Schuur J. Trends in hospital admission and surgical procedures following ED visits for diverticulitis. West J Emerg Med. 2016;17(4):409&#x2010;417. 10.5811/WESTJEM.2016.4.29757</Citation><ArticleIdList><ArticleId IdType="doi">10.5811/WESTJEM.2016.4.29757</ArticleId><ArticleId IdType="pmc">PMC4944797</ArticleId><ArticleId IdType="pubmed">27429691</ArticleId></ArticleIdList></Reference><Reference><Citation>Cammarota S, Cargiolli M, Andreozzi P, et al. Increasing trend in admission rates and costs for acute diverticulitis during 2005&#x2013;2015: real&#x2010;life data from the Abruzzo Region. Therap Adv Gastroenterol. 2018;11. 10.1177/1756284818791502</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756284818791502</ArticleId><ArticleId IdType="pmc">PMC6109850</ArticleId><ArticleId IdType="pubmed">30159036</ArticleId></ArticleIdList></Reference><Reference><Citation>Salem L, Flum DR. Primary anastomosis or hartmann's procedure for patients with diverticular peritonitis? A systematic review. Dis Colon Rectum. 2004;47(11):1953&#x2010;1964. 10.1007/S10350-004-0701-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10350-004-0701-1</ArticleId><ArticleId IdType="pubmed">15622591</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregersen R, Mortensen LQ, Burcharth J, Pommergaard HC, Rosenberg J. Treatment of patients with acute colonic diverticulitis complicated by abscess formation: A systematic review. Int J Surg. 2016;35:201&#x2010;208. 10.1016/J.IJSU.2016.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IJSU.2016.10.006</ArticleId><ArticleId IdType="pubmed">27741423</ArticleId></ArticleIdList></Reference><Reference><Citation>Detry R, Jamez J, Kartheuser A, et al. Acute localized diverticulitis: optimum management requires accurate staging. Int J Colorectal Dis. 1992;7(1):38&#x2010;42. 10.1007/BF01647660/METRICS</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01647660/METRICS</ArticleId><ArticleId IdType="pubmed">1588224</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafey A, Jahan S, Farooq U, et al. Antibiotics associated with clostridium difficile infection. Cureus. 2023;15(5):e39029. 10.7759/CUREUS.39029</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/CUREUS.39029</ArticleId><ArticleId IdType="pmc">PMC10266117</ArticleId><ArticleId IdType="pubmed">37323360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurti Z, et al. Burden of clostridium difficile infection between 2010 and 2013: trends and outcomes from an academic center in Eastern Europe. World J Gastroenterol. 2015;21(21):6728&#x2010;6735. 10.3748/WJG.V21.I21.6728</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/WJG.V21.I21.6728</ArticleId><ArticleId IdType="pmc">PMC4458783</ArticleId><ArticleId IdType="pubmed">26074711</ArticleId></ArticleIdList></Reference><Reference><Citation>King RN, Lager SL. Incidence of clostridium difficile infections in patients receiving antimicrobial and acid&#x2010;suppression therapy. Pharmacotherapy. 2011;31(7):642&#x2010;648. 10.1592/PHCO.31.7.642</Citation><ArticleIdList><ArticleId IdType="doi">10.1592/PHCO.31.7.642</ArticleId><ArticleId IdType="pubmed">21923450</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalili H, Bairami S, Kargar M. Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome. Acta Med Iranica. 2013;51(12):871&#x2010;878.</Citation><ArticleIdList><ArticleId IdType="pubmed">24442542</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoub M, Tomanguilo&#x2010;Chumbe J, Chittazhattu J, et al. S198 outpatient use of antibiotics in uncomplicated diverticulitis decreases hospital admissions. Am J Gastroenterol. 2023;118(10S):S148&#x2010;S149. 10.14309/01.AJG.0000950432.03215.62</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/01.AJG.0000950432.03215.62</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37769411</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2210-2612</ISSN><JournalIssue CitedMedium="Print"><Volume>111</Volume><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>International journal of surgery case reports</Title><ISOAbbreviation>Int J Surg Case Rep</ISOAbbreviation></Journal><ArticleTitle>Atypical presentation of a rare disorder; idiopathic myointimal hyperplasia of mesenteric veins (IMHMV): Report of two cases.</ArticleTitle><Pagination><StartPage>108839</StartPage><MedlinePgn>108839</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">108839</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijscr.2023.108839</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2210-2612(23)00968-9</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Idiopathic myointimal hyperplasia of mesenteric veins (IMHMV) is a rare type of chronic colonic ischemia. Patients commonly present with progressive abdominal pain, bloody diarrhea, and weight loss. IMHMV is a common mimicker of inflammatory bowel disease. However, medical management does not have a primary role and curative treatment is surgical resection.</AbstractText><AbstractText Label="PRESENTATION OF CASE" NlmCategory="METHODS">We report two cases of IMHMV with atypical presentation. The first is an 82-year-old male who had refractory, painless, explosive, and non-bloody diarrhea initially treated with antidiarrheal medications and dietary changes to no effect. Colonoscopy was not clarifying. However, CT scan had characteristic findings of IMHMV. He underwent partial colectomy and recovered well. The second case is a 59-year-old male who had recurrent episodes of sudden, massive diarrhea. He was initially treated for diverticulitis based on colonoscopy findings but did not experience relief. Eventually, MRI of the abdomen was suggestive of IMHMV. He underwent surgical resection, which confirmed the diagnosis of IMHMV. He was treated for Clostridioides difficile diarrhea five months after surgery and pulmonary embolism seven months after surgery. With over a year of follow up, neither has had disease recurrence.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Diagnosis and treatment of rare disorders like IMHMV is challenging, especially when they mimic common entities or present in atypical ways.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We present two cases to highlight IMHMV as part of the differential for colitis-like symptoms. These cases demonstrate the importance of diagnostic imaging in diagnosis. Diagnostic uncertainty can lead to exposure to ineffective medical treatments and delay in curative surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Himani</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreira</LastName><ForeName>Roger K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shawki</LastName><ForeName>Sherief F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rumer</LastName><ForeName>Kristen K</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: Rumer.Kristen@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Surg Case Rep</MedlineTA><NlmUniqueID>101529872</NlmUniqueID><ISSNLinking>2210-2612</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Case report</Keyword><Keyword MajorTopicYN="N">Chronic colonic ischemia</Keyword><Keyword MajorTopicYN="N">IMHMV</Keyword><Keyword MajorTopicYN="N">Idiopathic myointimal hyperplasia of mesenteric veins</Keyword><Keyword MajorTopicYN="N">Venous intimal hyperplasia</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare no conflict of interest. All procedures were performed in studies involving human participants followed the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declare and its later amendments or compared ethical strands.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37769411</ArticleId><ArticleId IdType="pmc">PMC10539920</ArticleId><ArticleId IdType="doi">10.1016/j.ijscr.2023.108839</ArticleId><ArticleId IdType="pii">S2210-2612(23)00968-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li H., Shu H., Zhang H., Cui M., Gao Y., Tian F. Idiopathic myointimal hyperplasia of the mesenteric veins: a case report and scoping review of previously reported cases from clinical features to treatment. Front. Med. (Lausanne) 2022;9:855335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9043287</ArticleId><ArticleId IdType="pubmed">35492366</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson B., Smyrk T.C., Graham R.P., Lightner A., Sweetser S. Idiopathic myointimal hyperplasia is a distinct cause of chronic colon ischaemia. Colorectal Dis. 2019;21(9):1073&#x2013;1078.</Citation><ArticleIdList><ArticleId IdType="pubmed">31074117</ArticleId></ArticleIdList></Reference><Reference><Citation>Genta R.M., Haggitt R.C. Idiopathic myointimal hyperplasia of mesenteric veins. Gastroenterology. 1991;101(2):533&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">2065929</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahara K., Yamada R., Fujiwara T., Koizumi K., Horiguchi S., Hishima T., et al. Idiopathic myointimal hyperplasia of mesenteric veins: rare case of ischemic colitis mimicking inflammatory bowel disease. Dig. Endosc. 2015;27(7):767&#x2013;770.</Citation><ArticleIdList><ArticleId IdType="pubmed">25777655</ArticleId></ArticleIdList></Reference><Reference><Citation>Agha R.A., Franchi T., Sohrabi C., Mathew G., Kerwan A. The SCARE 2020 guideline: updating consensus Surgical CAse REport (SCARE) guidelines. Int. J. Surg. 2020;84:226&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">33181358</ArticleId></ArticleIdList></Reference><Reference><Citation>Platz J., Hyman N. Idiopathic myointimal hyperplasia of mesenteric veins. Gastroenterol. Hepatol. (N. Y.) 2012;8(10):700&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969017</ArticleId><ArticleId IdType="pubmed">24683382</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaherty M.J., Lie J.T., Haggitt R.C. Mesenteric inflammatory veno-occlusive disease. A seldom recognized cause of intestinal ischemia. Am. J. Surg. Pathol. 1994;18(8):779&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">8037291</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccinin M.A., Schwartz J. StatPearls. 2023. StatPearls Publishing LLC; Treasure Island (FL): 2023. Histology, Verhoeff stain. StatPearls Publishing Copyright &#xa9;.</Citation><ArticleIdList><ArticleId IdType="pubmed">30085592</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin F.C., Yang L.S., Fehily S.R., D&#x2019;Souza B., Lim A., McKelvie P.A. Idiopathic myointimal hyperplasia of the mesenteric veins: case report and review of the literature. JGH Open. 2020;4(3):345&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273708</ArticleId><ArticleId IdType="pubmed">32514435</ArticleId></ArticleIdList></Reference><Reference><Citation>Feo L., Cheeyandira A., Schaffzin D.M. Idiopathic myointimal hyperplasia of mesenteric veins in the elderly. Int. J. Colorectal Dis. 2013;28(3):433&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">22562259</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Alfa A.K., Ayer U., West A.B. Mucosal biopsy findings and venous abnormalities in idiopathic myointimal hyperplasia of the mesenteric veins. Am. J. Surg. Pathol. 1996;20(10):1271&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pubmed">8827035</ArticleId></ArticleIdList></Reference><Reference><Citation>Yantiss R.K., Cui I., Panarelli N.C., Jessurun J. Idiopathic myointimal hyperplasia of mesenteric veins: an uncommon cause of ischemic colitis with distinct mucosal features. Am. J. Surg. Pathol. 2017;41(12):1657&#x2013;1665.</Citation><ArticleIdList><ArticleId IdType="pubmed">28817406</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao P.C., Vecchio J.A., Hyman N.H., West A.B., Blaszyk H. Idiopathic myointimal hyperplasia of mesenteric veins: a rare mimic of idiopathic inflammatory bowel disease. J. Clin. Gastroenterol. 2005;39(8):704&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">16082281</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong R., Westerveld D., Yeo H., Jessurun J., Jesudian A. Ischemic colitis from idiopathic myointimal hyperplasia of the mesenteric veins in a post-liver transplant patient. ACG Case Rep. J. 2021;8(11)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8568464</ArticleId><ArticleId IdType="pubmed">34746329</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36742171</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2219-2840</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>28</Day></PubDate></JournalIssue><Title>World journal of gastroenterology</Title><ISOAbbreviation>World J Gastroenterol</ISOAbbreviation></Journal><ArticleTitle>Trends in gastrointestinal disease hospitalizations and outcomes during the first year of the coronavirus pandemic.</ArticleTitle><Pagination><StartPage>744</StartPage><EndPage>757</EndPage><MedlinePgn>744-757</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3748/wjg.v29.i4.744</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The impact of the coronavirus on hospitalizations for gastrointestinal (GI) disease, particularly at a population level is understudied.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To investigate trends in hospitalizations, inpatient endoscopy resource utilization, and outcomes during the first year of the coronavirus pandemic and subsequent lockdowns.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using the California State Inpatient Database for 2018-2020, we explored year-to-year and 2020 month-to-month trends in hospitalizations, length of stay, and inpatient mortality (all-cause &amp; viral pneumonia-specific) for common inpatient GI diagnoses including acute pancreatitis, diverticulitis, cholelithiasis, non-infectious gastroenteritis, upper and lower GI bleeding (LGIB), <i>Clostridium difficile</i>, viral gastroenteritis, inflammatory bowel disease, and acute cholangitis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Disease-specific hospitalizations decreased for all included conditions except nonvariceal upper GI bleeding (NVUGIB), LGIB, and ulcerative colitis (UC) (ptrend &lt; 0.0001). All-cause inpatient mortality was higher in 2020 <i>vs</i> 2019, for acute pancreatitis (<i>P</i> = 0.029), diverticulitis (<i>P</i> = 0.04), NVUGIB (<i>P</i> = 0.003), and Crohn's disease (<i>P</i> = 0.004). In 2020, hospitalization rates were lowest in April, November, and December. There was no significant corresponding increase in inpatient mortality except in UC (ptrend = 0.048). Viral pneumonia and viral pneumonia complicated by respiratory failure increased (<i>P</i> &lt; 0.001) among GI hospitalizations. Endoscopy utilization within 24 h of admission was unchanged for GI emergencies except NVUGIB (<i>P</i> &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings suggest that hospitalization rates for common GI conditions significantly declined in California during the COVID pandemic, particularly in April, November and December 2020. All-cause mortality was significantly higher among acute pancreatitis, diverticulitis, NVUGIB, and Crohn's disease hospitalizations. Emergency endoscopy rates were mostly comparable between 2020 and 2019.</AbstractText><CopyrightInformation>&#xa9;The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adekunle</LastName><ForeName>Ayooluwatomiwa Deborah</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Division of Internal Medicine, St. Luke's Hospital, Chesterfield, MI 63017, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubens</LastName><ForeName>Muni</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Office of Clinical Research, Miami Cancer Institute, Miami, FL 33176, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedarous</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Internal Medicine, McMaster University, Hamilton ON L8S 4L8, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tariq</LastName><ForeName>Tahniyat</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Stanford University School of Medicine, Redwood City, CA 94063, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okafor</LastName><ForeName>Philip N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Stanford University College of Medicine, Redwood City, CA 94063, United States. philokafor@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Gastroenterol</MedlineTA><NlmUniqueID>100883448</NlmUniqueID><ISSNLinking>1007-9327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003424" MajorTopicYN="Y">Crohn Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010195" MajorTopicYN="Y">Pancreatitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="Y">Gastrointestinal Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006471" MajorTopicYN="N">Gastrointestinal Hemorrhage</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003093" MajorTopicYN="Y">Colitis, Ulcerative</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004238" MajorTopicYN="Y">Diverticulitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Gastrointestinal diseases</Keyword><Keyword MajorTopicYN="N">Hospitalizations</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Procedure utilization</Keyword><Keyword MajorTopicYN="N">Shelter-in-place</Keyword></KeywordList><CoiStatement>Conflict-of-interest statement: The authors have no relevant conflict of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>6</Day><Hour>3</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36742171</ArticleId><ArticleId IdType="pmc">PMC9896617</ArticleId><ArticleId IdType="doi">10.3748/wjg.v29.i4.744</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mafham MM, Spata E, Goldacre R, Gair D, Curnow P, Bray M, Hollings S, Roebuck C, Gale CP, Mamas MA, Deanfield JE, de Belder MA, Luescher TF, Denwood T, Landray MJ, Emberson JR, Collins R, Morris EJA, Casadei B, Baigent C. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet. 2020;396:381&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429983</ArticleId><ArticleId IdType="pubmed">32679111</ArticleId></ArticleIdList></Reference><Reference><Citation>Eshraghian A, Taghavi A, Nikeghbalian S, Malek-Hosseini SA. Reduced rate of hospital admissions for liver-related morbidities during the initial COVID-19 outbreak. Lancet Gastroenterol Hepatol. 2020;5:803&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324093</ArticleId><ArticleId IdType="pubmed">32615070</ArticleId></ArticleIdList></Reference><Reference><Citation>Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G, Cohn A, Fox L, Patel A, Gerber SI, Kim L, Tong S, Lu X, Lindstrom S, Pallansch MA, Weldon WC, Biggs HM, Uyeki TM, Pillai SK Washington State 2019-nCoV Case Investigation Team. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020;382:929&#x2013;936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092802</ArticleId><ArticleId IdType="pubmed">32004427</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeates EO, Juillard C, Grigorian A, Schellenberg M, Owattanapanich N, Barmparas G, Margulies D, Garber K, Cryer H, Tillou A, Burruss S, Penaloza-Villalobos L, Lin A, Figueras RA, Brenner M, Firek C, Costantini T, Santorelli J, Curry T, Wintz D, Biffl WL, Schaffer KB, Duncan TK, Barbaro C, Diaz G, Johnson A, Chinn J, Naaseh A, Leung A, Grabar C, Yeates TO, Nahmias J. The coronavirus disease 2019 (COVID-19) stay-at-home order's unequal effects on trauma volume by insurance status in Southern California. Surgery. 2021;170:962&#x2013;968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9757901</ArticleId><ArticleId IdType="pubmed">33849732</ArticleId></ArticleIdList></Reference><Reference><Citation>Matrajt L, Leung T. Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease. Emerg Infect Dis. 2020;26:1740&#x2013;1748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392458</ArticleId><ArticleId IdType="pubmed">32343222</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguoro I, Pilotto C, Vergine M, Pusiol A, Vidal E, Cogo P. The impact of COVID-19 on a tertiary care pediatric emergency department. Eur J Pediatr. 2021;180:1497&#x2013;1504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787709</ArticleId><ArticleId IdType="pubmed">33409588</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Chang CH, Hu CC, Chang Y, Hsieh PH, Lin YC. The Risk Factor and Outcome of Metachronous Periprosthetic Joint Infections: A Retrospective Analysis With a Minimum Ten-Year Follow-Up. J Arthroplasty. 2021;36:3734&#x2013;3740.</Citation><ArticleIdList><ArticleId IdType="pubmed">34419315</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartnett KP, Kite-Powell A, DeVies J, Coletta MA, Boehmer TK, Adjemian J, Gundlapalli AV National Syndromic Surveillance Program Community of Practice. Impact of the COVID-19 Pandemic on Emergency Department Visits - United States, January 1, 2019-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:699&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315789</ArticleId><ArticleId IdType="pubmed">32525856</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldujeli A, Hamadeh A, Briedis K, Tecson KM, Rutland J, Krivickas Z, Stiklioraitis S, Briede K, Aldujeili M, Unikas R, Zaliaduonyte D, Zaliunas R, Vallabhan RC, McCullough PA. Delays in Presentation in Patients With Acute Myocardial Infarction During the COVID-19 Pandemic. Cardiol Res. 2020;11:386&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7666599</ArticleId><ArticleId IdType="pubmed">33224384</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquechel K, Diwadkar AR, Sayed S, Dudley JW, Grundmeier RW, Kenyon CC, Henrickson SE, Himes BE, Hill DA. Pediatric Asthma Health Care Utilization, Viral Testing, and Air Pollution Changes During the COVID-19 Pandemic. J Allergy Clin Immunol Pract. 2020;8:3378&#x2013;3387.e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438361</ArticleId><ArticleId IdType="pubmed">32827728</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale R, Eberlein S, Fuller G, Khalil C, Almario CV, Spiegel BMR. Public Perspectives on Decisions About Emergency Care Seeking for Care Unrelated to COVID-19 During the COVID-19 Pandemic. JAMA Netw Open. 2021;4:e2120940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8377572</ArticleId><ArticleId IdType="pubmed">34410398</ArticleId></ArticleIdList></Reference><Reference><Citation>Oseran AS, Nash D, Kim C, Moisuk S, Lai PY, Pyhtila J, Sequist TD, Wasfy JH. Changes in hospital admissions for urgent conditions during COVID-19 pandemic. Am J Manag Care. 2020;26:327&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pubmed">32835458</ArticleId></ArticleIdList></Reference><Reference><Citation>Birkmeyer JD, Barnato A, Birkmeyer N, Bessler R, Skinner J. The Impact Of The COVID-19 Pandemic On Hospital Admissions In The United States. Health Aff (Millwood) 2020;39:2010&#x2013;2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7769002</ArticleId><ArticleId IdType="pubmed">32970495</ArticleId></ArticleIdList></Reference><Reference><Citation>Issaka RB, Feld LD, Kao J, Hegarty E, Snailer B, Kalra G, Tomizawa Y, Strate L. Real-World Data on the Impact of COVID-19 on Endoscopic Procedural Delays. Clin Transl Gastroenterol. 2021;12:e00365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8162484</ArticleId><ArticleId IdType="pubmed">34060496</ArticleId></ArticleIdList></Reference><Reference><Citation>Calderwood AH, Calderwood MS, Williams JL, Dominitz JA. Impact of the COVID-19 Pandemic on Utilization of EGD and Colonoscopy in the United States: An Analysis of the GIQuIC Registry. Tech Innov Gastrointest Endosc. 2021;23:313&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8323550</ArticleId><ArticleId IdType="pubmed">34345871</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahadev S, Aroniadis OS, Barraza L, Agarunov E, Goodman AJ, Benias PC, Buscaglia JM, Gross SA, Kasmin FE, Cohen JJ, Carr-Locke DL, Greenwald DA, Mendelsohn RB, Sethi A, Gonda TA NYSGE research committee. Impact of the COVID-19 pandemic on endoscopy practice: results of a cross-sectional survey from the New York metropolitan area. Gastrointest Endosc. 2020;92:788&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182511</ArticleId><ArticleId IdType="pubmed">32339595</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Doyle JB, Blackett JW, May B, Hur C, Lebwohl B HIRE study group. Effect of the Coronavirus 2019 Pandemic on Outcomes for Patients Admitted With Gastrointestinal Bleeding in New York City. Gastroenterology. 2020;159:1155&#x2013;1157.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217780</ArticleId><ArticleId IdType="pubmed">32405086</ArticleId></ArticleIdList></Reference><Reference><Citation>Milenkovic M, Russo CA, Elixhauser A. Hospital Stays for Gastrointestinal Diseases, 2004. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb-</Citation><ArticleIdList><ArticleId IdType="pubmed">21938841</ArticleId></ArticleIdList></Reference><Reference><Citation>James N, Menzies M, Radchenko P. COVID-19 second wave mortality in Europe and the United States. Chaos. 2021;31:031105.</Citation><ArticleIdList><ArticleId IdType="pubmed">33810707</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulet T, Spencer S, Abelson J. Impact of the Early COVID-19 surge on the Outcomes of Diverticulitis. Dis Colon Rectum. 2021;64:15.</Citation></Reference><Reference><Citation>Lau LHS, Wong SH, Yip TCF, Wong GLH, Wong VWS, Sung JJY. Collateral Effect of Coronavirus Disease 2019 Pandemic on Hospitalizations and Clinical Outcomes in Gastrointestinal and Liver Diseases: A Territory-wide Observational Study in Hong Kong. Gastroenterology. 2020;159:1979&#x2013;1981.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7382332</ArticleId><ArticleId IdType="pubmed">32721440</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciarleglio FA, Rigoni M, Mereu L, Tommaso C, Carrara A, Malossini G, Tateo S, Tirone G, Bjerklund Johansen TE, Benetollo PP, Ferro A, Guarrera GM, Grattarola M, Nollo G, Brolese A. The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access. World J Emerg Surg. 2021;16:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8276199</ArticleId><ArticleId IdType="pubmed">34256781</ArticleId></ArticleIdList></Reference><Reference><Citation>Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP) Introduction to the HCUP State Inpatient Databases (SID), Rockville, MD, 2021.</Citation></Reference><Reference><Citation>Metcalfe D, Zogg CK, Haut ER, Pawlik TM, Haider AH, Perry DC. Data resource profile: State Inpatient Databases. Int J Epidemiol. 2019;48:1742&#x2013;1742h.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6929527</ArticleId><ArticleId IdType="pubmed">31280297</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirode G, Saab S, Wong RJ. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults. JAMA Netw Open. 2020;3:e201997.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118516</ArticleId><ArticleId IdType="pubmed">32239220</ArticleId></ArticleIdList></Reference><Reference><Citation>Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, Jensen ET, Shaheen NJ, Barritt AS, Lieber SR, Kochar B, Barnes EL, Fan YC, Pate V, Galanko J, Baron TH, Sandler RS. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. Gastroenterology. 2019;156:254&#x2013;272.e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6689327</ArticleId><ArticleId IdType="pubmed">30315778</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, Weissman S, Mehta TI, Aziz M, Acharya A, Vohra I, Khan Z, Khan A, Nawras A, Sciarra M, Swaminath A. Role of Hospital Teaching Status on Outcomes of Patients with Inflammatory Bowel Disease: A Nationwide Analysis. Dig Dis Sci. 2021;66:2216&#x2013;2226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8385679</ArticleId><ArticleId IdType="pubmed">32696235</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">17938396</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud N, Hubbard RA, Kaplan DE, Serper M. Declining Cirrhosis Hospitalizations in the Wake of the COVID-19 Pandemic: A National Cohort Study. Gastroenterology. 2020;159:1134&#x2013;1136.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7200325</ArticleId><ArticleId IdType="pubmed">32387493</ArticleId></ArticleIdList></Reference><Reference><Citation>Findling MG, Blendon RJ, Benson JM. Delayed Care with Harmful Health Consequences-Reported Experiences from National Surveys During Coronavirus Disease 2019. JAMA Health Forum. 2020;1:e201463.</Citation><ArticleIdList><ArticleId IdType="pubmed">36218479</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon C. A timeline of California in the coronavirus pandemic, Sacramento, California, 2021.</Citation></Reference><Reference><Citation>Mallick B, Dhaka N, Sharma V, Malik S, Sinha SK, Dutta U, Gupta P, Gulati A, Yadav TD, Gupta V, Kochhar R. Impact of timing of presentation of acute pancreatitis to a tertiary care centre on the outcome. Pancreatology. 2019;19:143&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">30366676</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard MS, Tucker JS, Green HD Jr. Changes in Adult Alcohol Use and Consequences During the COVID-19 Pandemic in the US. JAMA Netw Open. 2020;3:e2022942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7525354</ArticleId><ArticleId IdType="pubmed">32990735</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa C, Cowell AJ, Dowd WN. Alcohol Consumption in Response to the COVID-19 Pandemic in the United States. J Addict Med. 2021;15:341&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8327759</ArticleId><ArticleId IdType="pubmed">33105169</ArticleId></ArticleIdList></Reference><Reference><Citation>Laine L, Barkun AN, Saltzman JR, Martel M, Leontiadis GI. ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding. Am J Gastroenterol. 2021;116:899&#x2013;917.</Citation><ArticleIdList><ArticleId IdType="pubmed">33929377</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo CLT, Wong SH, Lau LHS, Lui RNS, Mak JWY, Tang RSY, Yip TCF, Wu WKK, Wong GLH, Chan FKL, Lau JYW, Sung JJY. Timing of endoscopy for acute upper gastrointestinal bleeding: a territory-wide cohort study. Gut. 2022;71:1544&#x2013;1550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9279843</ArticleId><ArticleId IdType="pubmed">34548338</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35875313</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Ischemic Colitis Is a Risk Factor for Clostridium difficile Infection.</ArticleTitle><Pagination><StartPage>e26076</StartPage><MedlinePgn>e26076</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e26076</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.26076</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">&#xa0;Clostridium difficile infection (CDI) is an anaerobic infection that can carry detrimental outcomes for patients and is a growing burden to the US healthcare system. Various theories have been proposed for the etiopathogenesis of CDI, including antibiotic use, dysbiosis, and acid suppression.&#xa0;The role of ischemia in CDI has not been explored. We hypothesize that tissue ischemia is a risk factor for the development of CDI. The study aimed to assess whether ischemia was a risk factor for CDI using ischemic colitis as a target population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a case-control study using the National Inpatient Sample (NIS) database in 2013. The study group included all patients with ischemic colitis (ICD 9 Code: 557.0, 557.1, 557.9) and the control group included all patients with diverticulitis (ICD 9 Code: 562.11, 562.13). Univariable and multivariable analyses were performed to assess the risk factors associated with CDI (ICD 9 Code: 008.45). The case and control groups were compared using the chi-square test for analysis. Continuous variables were compared using t-tests and categorical variables were compared using Rao-Scott chi-square tests.&#xa0;In addition, multivariable logistic regression analysis was performed to assess the association between disease group and CDI while adjusting for confounders. Univariable analysis was performed to assess differences between subjects with ischemic colitis and those with diverticulitis; continuous variables were compared using t-tests and categorical variables were compared using Rao-Scott chi-square tests. All analyses were done using SAS (version 9.4, The SAS Institute, Cary, NC).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We analyzed more than 30 million hospitalizations in 2013, with 120,490 being Ischemic colitis-related admissions and 309,940 being diverticulitis-related admissions. The rate of CDI was more in the ischemic colitis group than in the diverticulitis group (odds ratio [OR] = 1.39; 95% confidence interval [CI] [1.03-1.88], p=0.03). After adjusting for all variables, multivariate analysis showed CDI was associated with ischemic colitis (OR = 2.06; 95% CI 1.59-2.65, p&lt;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">CDI was shown to be more prevalent in ischemic colitis than in diverticulitis control in this population-based study. As C. difficile is an anaerobe, we hypothesize that tissue hypoxia is a risk factor for its development. Further studies are needed to validate our findings.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022, Khazaaleh et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khazaaleh</LastName><ForeName>Shrouq</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, Cleveland Clinic Foundation, Cleveland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Adalberto J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alomari</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wadhwa</LastName><ForeName>Vaibhav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Gastroenterology, Cleveland Clinic Florida, Weston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Bhavan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Neurology, Division of Epilepsy, Penn State Health Milton S. Hershey Medical Center, Hershey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Gastroenterology and Hepatology, Columbia University Irving Medical Center, New York City, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clostridium difficile</Keyword><Keyword MajorTopicYN="N">diverticulitis colon</Keyword><Keyword MajorTopicYN="N">gut dysbiosis</Keyword><Keyword MajorTopicYN="N">hospitalization outcomes</Keyword><Keyword MajorTopicYN="N">ischemic colitis</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>25</Day><Hour>4</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35875313</ArticleId><ArticleId IdType="pmc">PMC9295079</ArticleId><ArticleId IdType="doi">10.7759/cureus.26076</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Multistate point-prevalence survey of health care-associated infections. Magill SS, Edwards JR, Bamberg W, et al. N Engl J Med. 2014;370:1198&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4648343</ArticleId><ArticleId IdType="pubmed">24670166</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology of Clostridium difficile-associated infections. Barbut F, Petit JC. Clin Microbiol Infect. 2001;7:405&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">11591202</ArticleId></ArticleIdList></Reference><Reference><Citation>Evidence-based answers from the Family Physicians Inquiries Network. Fashner J, Garcia M, Joseph S, Ribble L, Crowell K, Guthmann R. https://cdn.mdedge.com/files/s3fs-public/Document/September-2017/6009JFP_ClinInq1.pdf J Fam Pract. 2011;60</Citation></Reference><Reference><Citation>Spontaneous persistent pseudomembranous colitis related to Clostridium difficile in ischaemic bowel disease. Wu A. Br Med J (Clin Res Ed) 1982;284:1606&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1498497</ArticleId><ArticleId IdType="pubmed">6805624</ArticleId></ArticleIdList></Reference><Reference><Citation>Community-acquired toxigenic Clostridium difficile diarrhoea in the normoxaemic elderly who have received no antimicrobials: soft evidence for ischaemic colitis? Laing RB, Dykhuizen RS, Smith CC, Gould IW, Reid TM. Scott Med J. 1996;41:15&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">8658116</ArticleId></ArticleIdList></Reference><Reference><Citation>In vitro killing of nosocomial pathogens by acid and acidified nitrite. Rao A, Jump RL, Pultz NJ, Pultz MJ, Donskey CJ. Antimicrob Agents Chemother. 2006;50:3901&#x2013;3904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1635176</ArticleId><ArticleId IdType="pubmed">17065628</ArticleId></ArticleIdList></Reference><Reference><Citation>Diverticulitis in the United States: 1998-2005: changing patterns of disease and treatment. Etzioni DA, Mack TM, Beart RW Jr, Kaiser AM. Ann Surg. 2009;249:210&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">19212172</ArticleId></ArticleIdList></Reference><Reference><Citation>Antibiotics versus no antibiotics in the treatment of acute uncomplicated diverticulitis - a systematic review and meta-analysis. Tandon A, Fretwell VL, Nunes QM, Rooney PS. Colorectal Dis. 2018;20:179&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">29323778</ArticleId></ArticleIdList></Reference><Reference><Citation>ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI) Brandt LJ, Feuerstadt P, Longstreth GF, Boley SJ. Am J Gastroenterol. 2015;110:18&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">25559486</ArticleId></ArticleIdList></Reference><Reference><Citation>Prospective randomized clinical trial assessing the efficacy of a short course of intravenously administered amoxicillin plus clavulanic acid followed by oral antibiotic in patients with uncomplicated acute diverticulitis. Ribas Y, Bombard&#xf3; J, Aguilar F, et al. Int J Colorectal Dis. 2010;25:1363&#x2013;1370.</Citation><ArticleIdList><ArticleId IdType="pubmed">20526718</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonic ischemia. Brandt LJ, Boley SJ. Surg Clin North Am. 1992;72:203&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">1731384</ArticleId></ArticleIdList></Reference><Reference><Citation>Survival after acute colon diverticulitis treated in hospital. Edna TH, Jamal Talabani A, Lydersen S, Endreseth BH. Int J Colorectal Dis. 2014;29:1361&#x2013;1367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4197364</ArticleId><ArticleId IdType="pubmed">24986140</ArticleId></ArticleIdList></Reference><Reference><Citation>Systematic review on the treatment of ischaemic colitis. D&#xed;az Nieto R, Varcada M, Ogunbiyi OA, Winslet MC. Colorectal Dis. 2011;13:744&#x2013;747.</Citation><ArticleIdList><ArticleId IdType="pubmed">20374265</ArticleId></ArticleIdList></Reference><Reference><Citation>Systematic review of the management of ischaemic colitis. O'Neill S, Yalamarthi S. Colorectal Dis. 2012;14:0&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">22776101</ArticleId></ArticleIdList></Reference><Reference><Citation>Host and pathogen factors for Clostridium difficile infection and colonization. Loo VG, Bourgault AM, Poirier L, et al. N Engl J Med. 2011;365:1693&#x2013;1703.</Citation><ArticleIdList><ArticleId IdType="pubmed">22047560</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical outcomes in hospitalized patients with Clostridium difficile infection by age group. Lee HC, Kim KO, Jeong YH, Lee SH, Jang BI, Kim TN. Korean J Gastroenterol. 2016;67:81&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">26907483</ArticleId></ArticleIdList></Reference><Reference><Citation>Clostridium difficile infection health disparities by race among hospitalized adults in the United States, 2001 to 2010. Argamany JR, Delgado A, Reveles KR. BMC Infect Dis. 2016;16:454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5002147</ArticleId><ArticleId IdType="pubmed">27568176</ArticleId></ArticleIdList></Reference><Reference><Citation>Clostridium difficile infection in patients with chronic kidney disease. Keddis MT, Khanna S, Noheria A, Baddour LM, Pardi DS, Qian Q. Mayo Clin Proc. 2012;87:1046&#x2013;1053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3541867</ArticleId><ArticleId IdType="pubmed">23127731</ArticleId></ArticleIdList></Reference><Reference><Citation>Outcomes in community-acquired Clostridium difficile infection. Khanna S, Pardi DS, Aronson SL, Kammer PP, Baddour LM. Aliment Pharmacol Ther. 2012;35:613&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3293482</ArticleId><ArticleId IdType="pubmed">22229532</ArticleId></ArticleIdList></Reference><Reference><Citation>Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections. Mitchell BG, Gardner A. Antimicrob Resist Infect Control. 2012;1:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3436661</ArticleId><ArticleId IdType="pubmed">22958238</ArticleId></ArticleIdList></Reference><Reference><Citation>Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Kyne L, Hamel MB, Polavaram R, Kelly CP. Clin Infect Dis. 2002;34:346&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">11774082</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31497443</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month><Day>27</Day></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Methicillin-resistant Staphylococcus Aureus Colitis Secondary to Complicated Acute Diverticulitis: A Rare Case Report.</ArticleTitle><Pagination><StartPage>e5013</StartPage><MedlinePgn>e5013</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e5013</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.5013</ELocationID><Abstract><AbstractText>A 33-year-old obese female with a recent diagnosis of acute diverticulitis (AD) was admitted to the hospital for severe abdominal pain, intractable nausea and vomiting, and diarrhea two days following oral antibiotic treatment for AD. Stool cultures collected upon her readmission were negative for Clostridium difficile (C. difficile) antigen and toxins A and B, but were notable for methicillin-resistant Staphylococcus aureus (MRSA). She was started on intravenous (IV) piperacillin/tazobactam, IV vancomycin, and an oral liquid vancomycin solution, which resulted in rapid resolution of her symptoms. Unfortunately, her symptoms recurred two weeks later and she eventually underwent laparoscopic low anterior resection (LAR) of her colon for continued diverticulitis. This resulted in complete and continued resolution of her symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>Everett</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Internal Medicine, Nova Southeastern University's Dr. Kiran C. Patel College of Osteopathic Medicine, Davie, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dooley</LastName><ForeName>Allison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, Largo Medical Center, Largo, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vu</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Psychiatry, Largo Medical Center, Largo, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haq</LastName><ForeName>Furqan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Internal Medicine, Oak Hill Hospital, Tampa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferderigos</LastName><ForeName>Spiros</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, Largo Medical Center, Largo, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clostridium difficile</Keyword><Keyword MajorTopicYN="N">diverticulitis</Keyword><Keyword MajorTopicYN="N">mrsa colitis</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>6</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31497443</ArticleId><ArticleId IdType="pmc">PMC6716748</ArticleId><ArticleId IdType="doi">10.7759/cureus.5013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. N Engl J Med. 1978;298:531&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pubmed">625309</ArticleId></ArticleIdList></Reference><Reference><Citation>Antibiotic-associated diarrhea. Bartlett JG. Clin Infect Dis. 1992;15:573&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pubmed">1420669</ArticleId></ArticleIdList></Reference><Reference><Citation>Predominant staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-LukD. Gravet A, Rondeau M, Harf-Monteil C, Grunenberger F, Monteil H, Scheftel JM, Pr&#xe9;vost G. https://jcm.asm.org/content/37/12/4012/article-info. J Clin Microbiol. 1999;37:4012&#x2013;4019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC85868</ArticleId><ArticleId IdType="pubmed">10565923</ArticleId></ArticleIdList></Reference><Reference><Citation>Severe MRSA enterocolitis caused by a strain harboring enterotoxins D, G, and I. Bergevin M, Marion A, Farber D, Golding GR, L&#xe9;vesque S. Emerg Infect Dis. 2017;23:865&#x2013;867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5403038</ArticleId><ArticleId IdType="pubmed">28418301</ArticleId></ArticleIdList></Reference><Reference><Citation>Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant staphylococcus aureus. Boyce JM, Havill NL. https://insights.ovid.com/pubmed?pmid=16086721. Am J Gastroenterol. 2005;100:1828&#x2013;1834.</Citation><ArticleIdList><ArticleId IdType="pubmed">16086721</ArticleId></ArticleIdList></Reference><Reference><Citation>A rare case of acute colitis caused by methicillin-resistant staphylococcus aureus. Scott Scott, RE RE, Hayden Hayden, RL RL. https://www.consultant360.com/articles/rare-case-acute-colitis-caused-methicillin-resistant-staphylococcus-aureus Consultant. 2017;57:700&#x2013;701.</Citation></Reference><Reference><Citation>A rare case of infectious colitis. Kalakonda A, Garg S, Tandon S, Vinayak R, Dutta S. Gastroenterol Rep. 2016;4:328&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5193053</ArticleId><ArticleId IdType="pubmed">26014485</ArticleId></ArticleIdList></Reference><Reference><Citation>Pseudomembranous colitis secondary to methicillin-resistant staphylococcus aureus (MRSA) Pressly KB, Hill E, Shah KJ. BMJ Case Rep. 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4885368</ArticleId><ArticleId IdType="pubmed">27165998</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonic MRSA complicating ulcerative colitis. Mansoor M, Kaushik VY, Aslam MB. http://ispub.com/IJGE/10/2/7111 Internet Journal of Gastroenterology. 2010;10:2.</Citation></Reference><Reference><Citation>Antibiotic-associated diarrhea due to methicillin-resistant staphylococcus aureus. Lo TS, Borchardt SM. Diagn Microbiol Infect Dis. 2009;63:388&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pubmed">19232861</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29545957</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2090-6560</ISSN><JournalIssue CitedMedium="Print"><Volume>2018</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Case reports in hematology</Title><ISOAbbreviation>Case Rep Hematol</ISOAbbreviation></Journal><ArticleTitle>Refractory Abdominal Pain in a Patient with Chronic Lymphocytic Leukemia: Be Wary of Acquired Angioedema due to C1 Esterase Inhibitor Deficiency.</ArticleTitle><Pagination><StartPage>7809535</StartPage><MedlinePgn>7809535</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7809535</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2018/7809535</ELocationID><Abstract><AbstractText>Acquired angioedema due to C1 inhibitor deficiency (C1INH-AAE) is a rare and potentially fatal syndrome of bradykinin-mediated angioedema characterized by episodes of angioedema without urticaria. It typically manifests with nonpitting edema of the skin and edema in the gastrointestinal (GI) tract mucosa or upper airway. Edema of the upper airway and tongue may lead to life-threatening asphyxiation. C1INH-AAE is typically under-diagnosed because of its rarity and its propensity to mimic more common abdominal conditions and allergic reactions. In this article, we present the case of a 62-year-old male with a history of recently diagnosed chronic lymphocytic leukemia (CLL) who presented to our hospital with recurrent abdominal pain, initially suspected to have <i>Clostridium difficile</i> colitis and diverticulitis. He received a final diagnosis of acquired angioedema due to C1 esterase inhibitor deficiency due to concomitant symptoms of lip swelling, cutaneous nonpitting edema of his lower extremities, and complement level deficiencies. He received acute treatment with C1 esterase replacement and icatibant and was maintained on C1 esterase infusions. He also underwent chemotherapy for his underlying CLL and did not experience further recurrence of his angioedema.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abdulkareem</LastName><ForeName>Abdullateef</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9658-3495</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Reading Hospital, West Reading, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Souza</LastName><ForeName>Ryan S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Mayo Clinic Hospital, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mundorff</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Reading Hospital, West Reading, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shrestha</LastName><ForeName>Pragya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Reading Hospital, West Reading, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shogbesan</LastName><ForeName>Oluwaseun</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-4130-4137</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Reading Hospital, West Reading, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donato</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8294-6769</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Reading Hospital, West Reading, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Case Rep Hematol</MedlineTA><NlmUniqueID>101576456</NlmUniqueID><ISSNLinking>2090-6579</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>1</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29545957</ArticleId><ArticleId IdType="pmc">PMC5818943</ArticleId><ArticleId IdType="doi">10.1155/2018/7809535</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pappalardo E., Cicardi M., Duponchel C., et al. Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema. Journal of Allergy and Clinical Immunology. 2000;106(6):1147&#x2013;1154. doi: 10.1067/mai.2000.110471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mai.2000.110471</ArticleId><ArticleId IdType="pubmed">11112899</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi M., Zanichelli A. Acquired angioedema. Allergy, Asthma and Clinical Immunology. 2010;6(1):p. 14. doi: 10.1186/1710-1492-6-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1710-1492-6-14</ArticleId><ArticleId IdType="pmc">PMC2925362</ArticleId><ArticleId IdType="pubmed">20667117</ArticleId></ArticleIdList></Reference><Reference><Citation>Gobert D., Paule R., Ponard D., et al. A nationwide study of acquired C1-inhibitor deficiency in France: characteristics and treatment responses in 92 patients. Medicine. 2016;95(33):p. e4363. doi: 10.1097/md.0000000000004363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000004363</ArticleId><ArticleId IdType="pmc">PMC5370791</ArticleId><ArticleId IdType="pubmed">27537564</ArticleId></ArticleIdList></Reference><Reference><Citation>Henao M. P., Craig T., Kraschnewski J., Kelbel T. Diagnosis and screening of patients with hereditary angioedema in primary care. Therapeutics and Clinical Risk Management. 2016;12:701&#x2013;711. doi: 10.2147/TCRM.S86293.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TCRM.S86293</ArticleId><ArticleId IdType="pmc">PMC4859422</ArticleId><ArticleId IdType="pubmed">27194914</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson G., Edgar D., Trinder J. Angioedema of the tongue due to acquired C1 esterase inhibitor deficiency. Anaesthesia And Intensive Care. 2003;31(1):99&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">12635405</ArticleId></ArticleIdList></Reference><Reference><Citation>Bork K., Siedlecki K., Bosch S., Schopf R. E., Kreuz W. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clinic Proceedings. 2000;75(4):349&#x2013;354. doi: 10.4065/75.4.349.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/75.4.349</ArticleId><ArticleId IdType="pubmed">10761488</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolles S., Williams P., Carne E. A UK national audit of hereditary and acquired angioedema. Clinical and Experimental Immunology. 2014;175(1):59&#x2013;67. doi: 10.1111/cei.12159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12159</ArticleId><ArticleId IdType="pmc">PMC3898555</ArticleId><ArticleId IdType="pubmed">23786259</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballero T., Baeza M. L., Caba&#xf1;as R., et al. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. Journal of Investigational Allergology and Clinical Immunology. 2011;21(5):333&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">21905496</ArticleId></ArticleIdList></Reference><Reference><Citation>Cugno M., Castelli R., Cicardi M. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation. Autoimmunity Reviews. 2008;8(2):156&#x2013;159. doi: 10.1016/j.autrev.2008.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2008.05.003</ArticleId><ArticleId IdType="pubmed">19014872</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi M., Zingale L. C., Pappalardo E., Folcioni A., Agostoni A. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine. 2003;82(4):274&#x2013;281. doi: 10.1097/01.md.0000085055.63483.09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.md.0000085055.63483.09</ArticleId><ArticleId IdType="pubmed">12861105</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M. A., Castelli R. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity. Clinical Chemistry and Laboratory Medicine. 2016;54(2):207&#x2013;214. doi: 10.1515/cclm-2015-0195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2015-0195</ArticleId><ArticleId IdType="pubmed">26068904</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi M., Zanichelli A. Angioedema due to C1 inhibitor deficiency in 2010. Internal and Emergency Medicine. 2010;5(6):481&#x2013;486. doi: 10.1007/s11739-010-0408-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-010-0408-3</ArticleId><ArticleId IdType="pubmed">20496014</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung M., Rice L. &#x201c;Surgical&#x201d; abdomen in a patient with chronic lymphocytic leukemia: a case of acquired angioedema. Journal of Gastrointestinal Surgery. 2011;15(12):2262&#x2013;2266. doi: 10.1007/s11605-011-1718-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-011-1718-0</ArticleId><ArticleId IdType="pmc">PMC3220812</ArticleId><ArticleId IdType="pubmed">21997434</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi M. Acquired C1 Inhibitor Deficiency: Clinical Manifestations, Epidemiology, Pathogenesis, and Diagnosis. UptoDate. 2016</Citation></Reference><Reference><Citation>Zingale L. C., Castelli R., Zanichelli A., Cicardi M. Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. Immunology and Allergy Clinics of North America. 2006;26(4):669&#x2013;690. doi: 10.1016/j.iac.2006.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iac.2006.08.002</ArticleId><ArticleId IdType="pubmed">17085284</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi M., Lambertenghi Deliliers D., Zanichelli A., Zingale L. C., Castelli R. Lymphoproliferative disease and acquired C1 inhibitor (C1-INH) deficiency. Journal of Allergy and Clinical Immunology. 2007;119(1):p. S279. doi: 10.1016/j.jaci.2006.12.464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2006.12.464</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli R., Wu M. A., Arquati M., et al. High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency. British Journal of Haematology. 2016;172(6):902&#x2013;908. doi: 10.1111/bjh.13908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.13908</ArticleId><ArticleId IdType="pubmed">26728240</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacoub P., Fr&#xe9;meaux-Bacchi V., De Lacroix I., et al. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus. Arthritis and Rheumatism. 2001;44(8):1836&#x2013;1840. doi: 10.1002/1529-0131(200108)44:8&lt;1836::aid-art321&gt;3.0.co;2-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200108)44:8&lt;1836::aid-art321&gt;3.0.co;2-y</ArticleId><ArticleId IdType="pubmed">11508436</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelfand J., Boss G. R., Conley C. L., Reinhart R., Frank M. M. Acquired C1 esterase inhibitor deficiency and angioedema: a review. Medicine. 1979;58(4):321&#x2013;328. doi: 10.1097/00005792-197907000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005792-197907000-00004</ArticleId><ArticleId IdType="pubmed">449665</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukeba D., Chandrikakumari K., Giot J. B., et al. Autoimmune angioneurotic edema in a patient with Helicobacter pylori infection. Helicobacter. 2009;14(1):9&#x2013;11. doi: 10.1111/j.1523-5378.2009.00651.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-5378.2009.00651.x</ArticleId><ArticleId IdType="pubmed">19191890</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohyuddin G., Rabinowitz I. A patient with chronic lymphocytic leukemia and acquired angioedema: correlation of clinical and biochemical response to CLL therapy. Ecancermedicalscience. 2013;7:p. 292. doi: 10.3332/ecancer.2013.292.</Citation><ArticleIdList><ArticleId IdType="doi">10.3332/ecancer.2013.292</ArticleId><ArticleId IdType="pmc">PMC3575201</ArticleId><ArticleId IdType="pubmed">23441138</ArticleId></ArticleIdList></Reference><Reference><Citation>Klossowski N., Braun S. A., von Gruben V., et al. Acquired angioedema with C1-INH deficiency and accompanying chronic spontaneous urticaria in a patient with chronic lymphatic B cell leukemia. Der Hautarzt. 2015;66(10):723&#x2013;725. doi: 10.1007/s00105-015-3679-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00105-015-3679-9</ArticleId><ArticleId IdType="pubmed">26335859</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli R., Zanichelli A., Cicardi M., Cugno M. Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship. Critical Reviews in Oncology/Hematology. 2013;87(3):323&#x2013;332. doi: 10.1016/j.critrevonc.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.critrevonc.2013.02.004</ArticleId><ArticleId IdType="pubmed">23490322</ArticleId></ArticleIdList></Reference><Reference><Citation>Agostoni A., Ayg&#xf6;ren-P&#xfc;rs&#xfc;n E., Binkley K. E., et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. Journal of Allergy and Clinical Immunology. 2004;114(3):S51&#x2013;S131. doi: 10.1016/j.jaci.2004.06.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2004.06.047</ArticleId><ArticleId IdType="pmc">PMC7119155</ArticleId><ArticleId IdType="pubmed">15356535</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi M., Suffritti C., Perego F., Caccia S. Novelties in the diagnosis and treatment of angioedema. Journal of Investigational Allergology and Clinical Immunology. 2016;26(4):212&#x2013;221. doi: 10.18176/jiaci.0087.</Citation><ArticleIdList><ArticleId IdType="doi">10.18176/jiaci.0087</ArticleId><ArticleId IdType="pubmed">27470642</ArticleId></ArticleIdList></Reference><Reference><Citation>Branellec A., Bouillet L., Javaud N., et al. Acquired C1-inhibitor deficiency: 7 patients treated with rituximab. Journal of Clinical Immunology. 2012;32(5):936&#x2013;941. doi: 10.1007/s10875-012-9691-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-012-9691-2</ArticleId><ArticleId IdType="pubmed">22526593</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>